Login to Your Account



$40M Without Venture Funding

HDAC Firm Acetylon Adds $15M Equity Investment from Celgene

By Marie Powers
Staff Writer

Friday, February 10, 2012
Privately held biotech Acetylon Pharmaceuticals Inc. continued its string of successful private investments with a $15 million equity stake by Celgene Corp.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription